Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 10 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4QCY0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006396 | RNA processing | 6 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0031123 | RNA 3'-end processing | 7 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071076 | RNA 3' uridylation | 8 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 10 |
GO:0016779 | nucleotidyltransferase activity | 4 | 10 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 10 |
GO:0070569 | uridylyltransferase activity | 5 | 10 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 10 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 62 | 66 | PF00656 | 0.376 |
CLV_C14_Caspase3-7 | 83 | 87 | PF00656 | 0.420 |
CLV_NRD_NRD_1 | 270 | 272 | PF00675 | 0.332 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.366 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.406 |
CLV_PCSK_KEX2_1 | 270 | 272 | PF00082 | 0.312 |
CLV_PCSK_KEX2_1 | 291 | 293 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.366 |
CLV_PCSK_KEX2_1 | 365 | 367 | PF00082 | 0.352 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.373 |
CLV_PCSK_PC1ET2_1 | 291 | 293 | PF00082 | 0.354 |
CLV_PCSK_PC1ET2_1 | 365 | 367 | PF00082 | 0.382 |
CLV_PCSK_PC1ET2_1 | 91 | 93 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 380 | 384 | PF00082 | 0.509 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.434 |
DEG_SPOP_SBC_1 | 307 | 311 | PF00917 | 0.562 |
DOC_ANK_TNKS_1 | 349 | 356 | PF00023 | 0.394 |
DOC_MAPK_gen_1 | 356 | 364 | PF00069 | 0.501 |
DOC_MAPK_HePTP_8 | 39 | 51 | PF00069 | 0.350 |
DOC_MAPK_MEF2A_6 | 356 | 364 | PF00069 | 0.377 |
DOC_MAPK_MEF2A_6 | 42 | 51 | PF00069 | 0.499 |
DOC_PP2B_LxvP_1 | 211 | 214 | PF13499 | 0.376 |
DOC_PP4_FxxP_1 | 223 | 226 | PF00568 | 0.339 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.322 |
DOC_USP7_MATH_1 | 308 | 312 | PF00917 | 0.669 |
DOC_USP7_MATH_1 | 316 | 320 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 375 | 379 | PF00917 | 0.366 |
DOC_USP7_MATH_1 | 395 | 399 | PF00917 | 0.648 |
DOC_USP7_UBL2_3 | 164 | 168 | PF12436 | 0.268 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.394 |
LIG_14-3-3_CanoR_1 | 17 | 24 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 270 | 276 | PF00244 | 0.319 |
LIG_14-3-3_CanoR_1 | 306 | 316 | PF00244 | 0.533 |
LIG_Actin_WH2_2 | 236 | 251 | PF00022 | 0.405 |
LIG_AP2alpha_1 | 379 | 383 | PF02296 | 0.461 |
LIG_BRCT_BRCA1_1 | 311 | 315 | PF00533 | 0.668 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.394 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.249 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.445 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.270 |
LIG_FHA_1 | 333 | 339 | PF00498 | 0.421 |
LIG_FHA_1 | 384 | 390 | PF00498 | 0.519 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.502 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.382 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.372 |
LIG_LIR_Apic_2 | 221 | 226 | PF02991 | 0.333 |
LIG_LIR_Gen_1 | 178 | 188 | PF02991 | 0.300 |
LIG_LIR_Gen_1 | 252 | 259 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 274 | 284 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 154 | 159 | PF02991 | 0.257 |
LIG_LIR_Nem_3 | 178 | 183 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.257 |
LIG_LIR_Nem_3 | 274 | 279 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 294 | 298 | PF02991 | 0.201 |
LIG_LIR_Nem_3 | 340 | 345 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 363 | 367 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 378 | 382 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.306 |
LIG_Pex14_2 | 379 | 383 | PF04695 | 0.345 |
LIG_SH2_CRK | 276 | 280 | PF00017 | 0.426 |
LIG_SH2_GRB2like | 345 | 348 | PF00017 | 0.271 |
LIG_SH2_PTP2 | 159 | 162 | PF00017 | 0.250 |
LIG_SH2_STAP1 | 276 | 280 | PF00017 | 0.293 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.252 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 345 | 348 | PF00017 | 0.293 |
LIG_SH3_3 | 169 | 175 | PF00018 | 0.302 |
LIG_SUMO_SIM_anti_2 | 189 | 195 | PF11976 | 0.386 |
LIG_SUMO_SIM_anti_2 | 263 | 268 | PF11976 | 0.269 |
LIG_SUMO_SIM_par_1 | 35 | 41 | PF11976 | 0.413 |
LIG_TRAF2_1 | 319 | 322 | PF00917 | 0.413 |
LIG_TRFH_1 | 223 | 227 | PF08558 | 0.371 |
LIG_WRC_WIRS_1 | 180 | 185 | PF05994 | 0.274 |
LIG_WRC_WIRS_1 | 220 | 225 | PF05994 | 0.444 |
LIG_WRC_WIRS_1 | 402 | 407 | PF05994 | 0.434 |
LIG_WW_1 | 226 | 229 | PF00397 | 0.352 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.409 |
MOD_CK1_1 | 309 | 315 | PF00069 | 0.531 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.288 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.364 |
MOD_CK2_1 | 316 | 322 | PF00069 | 0.576 |
MOD_CK2_1 | 397 | 403 | PF00069 | 0.596 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.365 |
MOD_Cter_Amidation | 3 | 6 | PF01082 | 0.439 |
MOD_Cter_Amidation | 348 | 351 | PF01082 | 0.306 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.377 |
MOD_GlcNHglycan | 294 | 298 | PF01048 | 0.383 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.354 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.393 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.305 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.570 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.530 |
MOD_GSK3_1 | 397 | 404 | PF00069 | 0.616 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.439 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.490 |
MOD_N-GLC_1 | 260 | 265 | PF02516 | 0.368 |
MOD_N-GLC_1 | 375 | 380 | PF02516 | 0.485 |
MOD_N-GLC_1 | 395 | 400 | PF02516 | 0.460 |
MOD_N-GLC_1 | 73 | 78 | PF02516 | 0.356 |
MOD_N-GLC_2 | 112 | 114 | PF02516 | 0.311 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.291 |
MOD_NEK2_1 | 320 | 325 | PF00069 | 0.423 |
MOD_NEK2_1 | 383 | 388 | PF00069 | 0.433 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.301 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.312 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.206 |
MOD_NEK2_2 | 175 | 180 | PF00069 | 0.343 |
MOD_NEK2_2 | 375 | 380 | PF00069 | 0.376 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.386 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.323 |
MOD_PKA_2 | 355 | 361 | PF00069 | 0.407 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.273 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.309 |
MOD_Plk_1 | 209 | 215 | PF00069 | 0.337 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.463 |
MOD_Plk_1 | 320 | 326 | PF00069 | 0.406 |
MOD_Plk_1 | 375 | 381 | PF00069 | 0.539 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.265 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.480 |
MOD_Plk_4 | 186 | 192 | PF00069 | 0.331 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.284 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.389 |
MOD_SUMO_rev_2 | 358 | 367 | PF00179 | 0.465 |
TRG_DiLeu_BaLyEn_6 | 106 | 111 | PF01217 | 0.253 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.250 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.323 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.305 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.320 |
TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.298 |
TRG_ENDOCYTIC_2 | 368 | 371 | PF00928 | 0.436 |
TRG_ER_diArg_1 | 269 | 271 | PF00400 | 0.299 |
TRG_ER_diArg_1 | 32 | 35 | PF00400 | 0.277 |
TRG_ER_diArg_1 | 350 | 352 | PF00400 | 0.366 |
TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.333 |
TRG_Pf-PMV_PEXEL_1 | 150 | 154 | PF00026 | 0.292 |
TRG_Pf-PMV_PEXEL_1 | 273 | 278 | PF00026 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 365 | 369 | PF00026 | 0.459 |
TRG_Pf-PMV_PEXEL_1 | 6 | 11 | PF00026 | 0.265 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7H1 | Leptomonas seymouri | 64% | 100% |
A0A0S4J0S6 | Bodo saltans | 56% | 100% |
A0A1X0NX27 | Trypanosomatidae | 55% | 100% |
A0A3Q8IDK5 | Leishmania donovani | 96% | 100% |
A0A422NJM7 | Trypanosoma rangeli | 54% | 88% |
A4HYQ1 | Leishmania infantum | 96% | 100% |
C7AJA4 | Trypanosoma brucei brucei | 52% | 100% |
C9ZI80 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AUK4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q6DFA8 | Xenopus laevis | 25% | 80% |